Viewing Study NCT03404193


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT03404193
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-05
First Post: 2018-01-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module